IMI 2 will hold an Open Info Day on its IMI 2-Call 1 in Brussels, Belgium on Tuesday 30 September 2014. The deadline for registration is the 23 September 2014.
On behalf of the President of EAMBES, Prof. Birgit Glasmacher, we hereby cordially invite you to attend the next GC and GA Meeting, organized during the 48th DGBMT Annual Conference (within VDE) in Hannover, Germany (www.bmt2014.de).
Deadline for this call is extended to October 15th
Just a quick reminder that the NBC16/MTD10 in Goteborg is approaching.
On her website on 17 September 2014, Mrs. Willmott stated that “we must ensure the industry is transparent and works in the interest of patients. This legislation will go a long way to achieving that and I look forward to taking it further in the coming months” She also expressed concern that the responsibility for medical devices policy will not fall under the auspices of DG Enterprise, following a decision by Mr. Junker which is being increasingly criticized by key EU stakeholders. As rapporteur for the Clinical Trials Regulation and a long-standing health-focused MEP, Mrs. Willmott was one of three main MEPs tipped to be the next Rapporteur of the MDR who will take over from ousted MEP Ms. Dagmar Roth-Behrendt (S&D, Germany). The other two potential MEPs that were suggested were Ms. Linda McAvan (S&D, UK) and Ms. Christel Schaldemose (S&D, Denmark). While Ms. Willmott did not take a central role in the discussions on the Medical Devices Regulation during the previous Parliamentary term, her focus during the Clinical Trials Regulation was on improving transparency and safety for patients.
Also on behalf of Adriana Velazquez Berumen of the WHO we cordially invite you and your colleagues in the development of a WHO global repository of Biomedical Engineering and its role on medical devices field, specifically on: country profiles, academic institutions, government, and professional organizations. (This news item is an adaptation of the mail she send out earlier this year)
On the 24 July 2014 it was reported that the European Commission has responded to criticism from over 700 scientists and students about the validity of the €1.2 billion Human Brain Project (HBP), one of the Horizon 2020 calls and indeed one of the largest EU-funded initiatives.
On the 11 August 2014, the European Commission reported that the Collective Experience of Empathic Data Systems (CEEDs) project is developing novel, integrated technologies to support analysis and understanding of robust datasets. CEEDs is a large project consising of 16 partners in 9 countries (Finland, France, Germany, Greece, Hungary, Italy, Spain, the Netherlands and the UK) who are coordinating efforts so as to optimise human understanding of Big Data.
In Europe we have three regional conferences. The Nordic-Baltic, The Medicon, and the pan-european (E)MBEC meeting. We are looking for societies to organize anyone of these. The next meeting of Medicon will be in Cyprus in 2016.
It is with great sadness that we have to inform you that on July 31st 2014 Lodewijk Bos passed away.
Call for candidates. Deadline extended until August 24th.
WHO resolution number 20; conference; forum; and request for input for the new edition of the regulations book.
On 04 July 2014, the General Secretariat of the Council of the European Union published a document addressed to the Working Party on Pharmaceuticals and Medical Devices in relation to the Council’s modifications to the Proposal for a Medical Devices Regulation. The document specifically deals with chapter VI on Clinical Evaluation and Clinical Investigations under the MDR and the in-vitro Medical Devices Regulation.
New UK report highlights the need for urgent action to prioritise the role of biomedical engineers in the NHS
The urgent need for biomedical engineers in the UK National Health Executive (NHS), the world’s largest healthcare system was highlighted by a new report entitled: Biomedical Engineering: Advancing UK healthcare. The report was published by the Institution of Mechanical Engineers UK on the 25 July 2014.
IMI 2 will hold an Open Info Day on its IMI 2-Call 1 in Brussels, Belgium on Tuesday 30 September 2014. In a similar vein to the Webinars held in July, the day will encompass an overview of IMI 2’s funding and intellectual property (IP) rules, funding advice so as to facilitate ease of applying under IMI 2, and workshops and presentations of the IMI 2-Call 1 Call topics by the project coordinator. Additionally, there will be plenty of networking opportunities and IMI staff will be on hand to answer questions relating to the new Call topics and the IMI 2 application procedures. It is important to note that additional information about the IMI 2-Call 1 will be communicated after approval by the IMI Governing Board (July/August 2014).
The Innovative Medicines Imitative 2 (IMI) has announced that it will hold a total of three webinars from the 11-15 July 2014 so as to better acquaint those wishing to apply for the IMI 2–Call 1 for proposals with the application process and the subject matters of the recently announce initial calls . This information was published in the IMI newsletter on the 30 June.
EAMBES have responded to the mHealth consultation which was launched by the European Commission on the 10 April 2014 and which could serve to promote the value Biomedical Engineering (BME).
The European Research Council (ERC) Work Programme for 2015 has been published on 23 July 2014. The ERC which is funded under Horizon 2020 has the unique idea of not having any particular topics as set criteria for funding and instead relies solely on the “excellence in science” principle to provide long-term funding for high-risk/ground breaking scientific pursuits.
On the 15 July 2014 Mr. Jean-Claude Juncker was elected as the President of the European Commission (EC) for the next legislative term. Mr. Juncker was elected following a 47-minute speech before a secret ballot, with 422 votes in favour (376 needed), 250 votes against, 47 abstentions and 10 void ballots.
On the 30 June 2014, the new Italian Presidency published a document setting out the Council’s work programme as established by the future trio of Presidencies (Italy, Latvia and Luxembourg), covering the period July 2014 to December 2015.